Posted by Michael Wonder on 29 Jun 2021
Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drug
29 June 2021 - The company has made a bigger push into health care as it tries to leverage its massive reach for new opportunities.
Walmart said Tuesday it will offer a less expensive version of insulin that could better fit into the budgets of millions of Americans who don’t have health insurance or struggle to pay for the life-saving diabetes drug.
Starting this week, the retailer will sell an exclusive private-label version of analog insulin, ReliOn NovoLog, to adults and children who have a prescription. The drug will be available at its membership-based Sam’s Club in mid-July. The insulin will cost about $73 for a vial or about $86 for a package of pre-filled insulin pens.
